[go: up one dir, main page]

DK1372728T3 - Sammensætning omfattende en olie-i-vand-emulsion indeholdende konjugeret linolensyre - Google Patents

Sammensætning omfattende en olie-i-vand-emulsion indeholdende konjugeret linolensyre

Info

Publication number
DK1372728T3
DK1372728T3 DK02704908.9T DK02704908T DK1372728T3 DK 1372728 T3 DK1372728 T3 DK 1372728T3 DK 02704908 T DK02704908 T DK 02704908T DK 1372728 T3 DK1372728 T3 DK 1372728T3
Authority
DK
Denmark
Prior art keywords
oil
composition
linoleic acid
water emulsion
emulsion containing
Prior art date
Application number
DK02704908.9T
Other languages
English (en)
Inventor
Jan Remmereit
Jo Klaveness
Original Assignee
Aker Biomarine Asa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aker Biomarine Asa filed Critical Aker Biomarine Asa
Application granted granted Critical
Publication of DK1372728T3 publication Critical patent/DK1372728T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/231Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having one or two double bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK02704908.9T 2001-03-07 2002-03-07 Sammensætning omfattende en olie-i-vand-emulsion indeholdende konjugeret linolensyre DK1372728T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0105622.5A GB0105622D0 (en) 2001-03-07 2001-03-07 Compositions
PCT/GB2002/000996 WO2002070014A1 (en) 2001-03-07 2002-03-07 Compositions comprising an o/w emulsion containing conjugated linoleic acid

Publications (1)

Publication Number Publication Date
DK1372728T3 true DK1372728T3 (da) 2013-05-13

Family

ID=9910159

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02704908.9T DK1372728T3 (da) 2001-03-07 2002-03-07 Sammensætning omfattende en olie-i-vand-emulsion indeholdende konjugeret linolensyre

Country Status (8)

Country Link
US (1) US8349894B2 (da)
EP (1) EP1372728B1 (da)
AU (1) AU2002238710B2 (da)
CA (1) CA2455226C (da)
DK (1) DK1372728T3 (da)
ES (1) ES2404656T3 (da)
GB (1) GB0105622D0 (da)
WO (1) WO2002070014A1 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO317310B1 (no) 2003-02-28 2004-10-04 Bioli Innovation As Olje-i-vann emulsjonskonsentrat for ernaeringsformal, samt anvendelse derav.
US20050215641A1 (en) * 2004-03-10 2005-09-29 Asgeir Saebo Compositions comprising reverse isomers of conjugated linoleic acid
US20060051462A1 (en) * 2004-09-03 2006-03-09 Wang Jimmy X Self emulsifying compositions for delivering lipophilic coenzyme Q10 and other dietary ingredients
DE102004043824A1 (de) 2004-09-10 2006-03-16 Cognis Ip Management Gmbh Emulsionen mit ungesättigten Fettsäuren und deren Estern
ES2335959B1 (es) * 2008-08-27 2011-02-11 Laboratorios Casen-Fleet, S.L. Composicion alimenticia que incorpora acido linoleico conjugado.
US8993625B2 (en) 2009-03-11 2015-03-31 Stable Solutions Llc Method of mitigating adverse drug events using omega-3 fatty acids as a parenteral therapeutic drug vehicle
US9034389B2 (en) * 2009-03-11 2015-05-19 Stable Solutions Llc Omega-3 enriched fish oil-in-water parenteral nutrition emulsions
EP2301523A1 (de) 2009-09-22 2011-03-30 Dr. August Wolff GmbH & Co. KG Arzneimittel Galenische Formulierung in kolloidaler Form
ES2607715B1 (es) 2015-10-01 2018-01-17 Solutex Na, Lcc Proceso para la preparación y estabilización de emulsiones con omega-3 mediante redes cristalinas isométricas de derivados de celulosa
CN113142585B (zh) * 2021-04-17 2025-02-18 青岛卓迪生物技术有限公司 一种共轭亚油酸纳米乳液及其制备方法
WO2023076042A1 (en) * 2021-10-27 2023-05-04 Quicksilver Scientific, Inc. Transdermal microemulsion delivery systems for alcohol-soluble species including nonderivatized hormones

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3549555A (en) * 1968-10-08 1970-12-22 Ncr Co Encapsulation of lipophilic liquid-in-hydrophilic liquid emulsions
US3996355A (en) * 1975-01-02 1976-12-07 American Home Products Corporation Permanent suspension pharmaceutical dosage form
US4292310A (en) * 1977-05-09 1981-09-29 Gordon Harry W Method of treating hypercholesterolemia with n-acyl amphotericin B
US4663167A (en) * 1984-04-16 1987-05-05 The Board Of Regents Of The University Of Texas System Composition and method for treatment of disseminated fungal infections in mammals
US5091389A (en) * 1991-04-23 1992-02-25 Merck & Co., Inc. Lipophilic macrolide useful as an immunosuppressant
US5554646A (en) * 1992-04-29 1996-09-10 Wisconsin Alumni Research Foundation Method for reducing body fat in animals
JP3862295B2 (ja) * 1993-09-30 2006-12-27 独立行政法人理化学研究所 抗肥満剤
US5760082C1 (en) 1994-08-29 2001-03-06 Wisconsin Alumni Res Found Dietetic foods containing conjugated linoleic acids
US5760083A (en) 1996-08-07 1998-06-02 Wisconsin Alumni Research Foundation Use of CLA to reduce the incidence of valgus and varus leg deforomities in poultry
US5837733A (en) * 1997-02-26 1998-11-17 Wisconsin Alumni Research Foundation Method for reducing secetion of apolipoprotein B in animals by administering conjugated linoleic acid
US5885594A (en) * 1997-03-27 1999-03-23 The Procter & Gamble Company Oral compositions having enhanced mouth-feel
EP1005277A4 (en) * 1997-08-18 2001-08-29 Univ South Dakota Dairy products with enhanced cla content
JP4129566B2 (ja) * 1997-09-05 2008-08-06 大塚製薬株式会社 肝臓脂肪蓄積抑制組成物及び肝臓脂肪蓄積抑制用食品添加剤
US6019990A (en) 1997-11-21 2000-02-01 Natural Nutrition Ltd. As Conjugated linoleic acid delivery system in cosmetic preparations
KR100402040B1 (ko) * 1998-05-04 2003-10-17 콘린코 인크. 이성질체가 강화된 공액 리놀레산 조성물의 이용 방법
US6060514A (en) 1998-05-04 2000-05-09 Conlin Co., Inc. Isomer enriched conjugated linoleic acid compositions
WO2000000186A1 (en) * 1998-06-30 2000-01-06 American Medical Research, Inc. Method of treating topical ailments
US6555579B2 (en) * 1998-08-13 2003-04-29 The Wistar Institute Methods for reducing atherosclerotic plaques
FR2784268B1 (fr) * 1998-10-12 2000-12-29 Gervais Danone Sa Nouvelle composition alimentaire, a base de matiere issue du lait, sous la forme d'une emulsion huile dans eau
EP1175158A1 (en) 1999-05-07 2002-01-30 Trustees Of Tufts College Immune stimulating dietary supplement and methods of use thereof
GB9918025D0 (en) 1999-07-30 1999-09-29 Unilever Plc Skin care composition
GB9918028D0 (en) 1999-07-30 1999-09-29 Unilever Plc Skin care composition

Also Published As

Publication number Publication date
CA2455226C (en) 2010-05-18
WO2002070014A1 (en) 2002-09-12
EP1372728A1 (en) 2004-01-02
ES2404656T3 (es) 2013-05-28
CA2455226A1 (en) 2002-09-12
AU2002238710B2 (en) 2007-09-06
WO2002070014A8 (en) 2003-11-27
US20040077724A1 (en) 2004-04-22
EP1372728B1 (en) 2013-02-20
GB0105622D0 (en) 2001-04-25
US8349894B2 (en) 2013-01-08

Similar Documents

Publication Publication Date Title
IL156215A0 (en) Oil-in-water emulsion formulation of insecticides
NO2008006I2 (no) Fluticasone furoate
FR2804025B1 (fr) Compositions pharmaceutiques stabilisees
DE60106275T8 (de) Dermatologische zusammensetzung
NO20025450L (no) Ny farmasöytisk sammensetning
CY2013011I1 (el) Μεθοδος χορηγησης διφωσφονικων
CY2007029I1 (el) Μεθοδος για την παρασκευη υποκατεστημενων οκτανοϋλ-αμιδιων
DE60114145D1 (de) Fulvestrant formulierung
NO20032587D0 (no) ABCA-1 eleverende forbindelser
NO20033785D0 (no) Farmasöytisk formulering
DK1395242T3 (da) Flydende farmaceutisk sammensætning
FI20002644L (fi) Liitäntäalusta
DE50101916D1 (de) Flüssige formulierungen
DK1372728T3 (da) Sammensætning omfattende en olie-i-vand-emulsion indeholdende konjugeret linolensyre
EE200400080A (et) Stendid
NO20042502L (no) Farmasoytisk formulering omfattende bicalutamid
NO20040614L (no) Preparater som inneholder konjugert linolalkohol.
DE50108104D1 (de) Beta-thio-aminosäuren
DE60143052D1 (de) Lipid vom carbonsäuretyp
DE60107787D1 (de) Wässrige Zusammensetzung aus Emulsionsacryl-polymeren
DE60011625D1 (de) Cisplatin enthaltende parenterale emulsion
NO990925L (no) Emulsjonsrigg
NO20032957D0 (no) Farmasöytisk emulsjonspreparat
FI20010970L (fi) Nestekoostumus
NO20050920L (no) Konjugert linolsyrepulver